Drug intelligence / Profile preview

rhizoma anemarrhenae

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Rhizoma Anemarrhenae is the dried rhizome of Anemarrhena asphodeloides Bunge and is a traditional Chinese medicinal herb known as "zhi mu" (知母). It is primarily used to clear heat and purge fire from the body—especially excess heat in the lung and stomach meridians—and to nourish yin and moisten dryness. The main active constituents are mangiferin (a xanthone glycoside with anti-inflammatory and antioxidant properties) and steroidal saponins such as sarasapogenin and timosaponin AII/BII. Pharmacological studies indicate anti-inflammatory, antidiabetic (by reducing insulin resistance), antimicrobial, antiplatelet aggregation, anticancer activity, neuroprotective effects (improving memory), bone-protective effects via promotion of bone formation by steroidal saponins, immune modulation properties, reduction of body temperature in febrile states ("heat-clearing"), phlegm expulsion from lungs due to lung heat or yin deficiency coughs. In Traditional Chinese Medicine it is indicated for high fever with thirst/irritability/sweating; cough due to lung heat; dry cough from yin deficiency; diabetes/prediabetes ("wasting & thirsting"); menopausal symptoms like night sweats/hot flushes; constipation due to intestinal dryness; oral ulcers/inflammation. It can be administered orally as decoction/powder/pill/capsule/tea using 6–12g dried herb per day[1][2][3][4][5][8].

Brand names
Zhi Mu
Other names
zhi muanemarrhena rhizomeknow mother root知母zhi mu pian蚳母连母野蓼
02

Targets

ABCB1 (P-glycoprotein)

Beyond the preview

Go deeper on rhizoma anemarrhenae.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rhizoma anemarrhenae.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call